Wordt geladen...
A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge
Coxsackievirus A16 (CA16) has caused worldwide epidemics of hand, foot and mouth disease (HFMD), particularly in infants and pre-school children. Currently, there are no vaccines or antiviral drugs available for CA16-associated disease. In this study, a CA16-specific monoclonal antibody (MAb) NA11F1...
Bewaard in:
| Gepubliceerd in: | Hum Vaccin Immunother |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816366/ https://ncbi.nlm.nih.gov/pubmed/30735461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1565266 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|